Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S5W-18970 · Session 5

Whether it will provide an update on progress being made to deliver the recommendations of the Montgomery Review of Access to New Medicines.

Answered Asked by Miles Briggs Con Lodged 20 Sep 2018

The question

To ask the Scottish Government whether it will provide an update on progress being made to deliver the recommendations of the Montgomery Review of Access to New Medicines.

The answer

Answered by Jeane Freeman on 27 Sep 2018 · 7 days after it was lodged, on time

We are continuing to work towards the implementation of the recommendations from the Review of Access to New Medicines.
Recent developments include the publication of the Access to Medicines Data Scoping Taskforce Report “Building Capability to Assess Real-World Benefits, Risk and Value of Medicines: Towards a Scottish Medicines Intelligence Unit”. The new “Ultra-Orphan” decision pathway will also begin to come into place from October 2018. And the Scottish Medicines Consortium (SMC) continues to enhance its effectiveness and accessibility to the public, and has now begun to publish new explanatory leaflets about individual decisions.
From August 2018, the SMC also introduced interim accepted advice for medicines with a conditional marketing authorisation from the European Medicines Agency.

In the Official Report

No contribution in the Official Report cites S5W-18970 by reference.